-
- New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs
- Masimo (NASDAQ: MASI) today announced the findings of a study published in the Journal of Patient Safety in which Dr. George Blike and colleagues at Dartmouth-Hitchcock Medical Center in New Hampshire demons...
- 14:25
-
- Rubedo Life Sciences Announces U.S. FDA Clearance of IND for Selective GPX4 Modulating Lead Drug Candidate RLS-1496 for Actinic Keratosis, Expands Clinical Advisory Board
- Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced that t...
- 14:40
-
- SBC Medical Accelerates Multi-Brand Strategy with Hybrid Dermatology Model “Hada no Aozora Clinic” Establishment
- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the...
- 14:40
-
- New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs
- Masimo (NASDAQ: MASI) today announced the findings of a study published in the Journal of Patient Safety in which Dr. George Blike and colleagues at Dartmouth-Hitchcock Medical Center in New Hampshire demons...
- 14:25
-
- Kinaxis to Host Inaugural European User Conference Showcasing Supply Chain Innovators
- Kinaxis® Inc. (TSX: KXS), a global leader in end-to-end supply chain orchestration, today announced its inaugural customer conference in Europe. Kinexions EMEA 2025 will be held October 6 - 8 in Amsterdam NL...
- 14:20
전시회
